Eric K. Steffe
Posts by Eric K. Steffe
Courts have long held that "an old product made by a new process is not novel and cannot be patented." The validity of product claims have generally …
Eric K. Steffe is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Eric’s practice involves providing strategic counsel to his clients in various areas of patent law, with special emphasis on therapeutic antibodies, gene therapies, CRISPR, vaccines, diagnostics, antisense technologies, personalized medicine, and cell culturing/bioprocessing methods.